Ken Griffin Tilray Brands, Inc. Call Options Transaction History

Citadel Advisors LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2025 Aug 14, 2025	SELL	$0.36 - $0.65 $197,316 - $356,265	-548,100 Reduced 24.53%	1,686,300 $691,000
Q1 2025 May 15, 2025	SELL	$0.59 - $1.46 $150,686 - $372,884	-255,400 Reduced 10.26%	2,234,400 $1.47 Million
Q4 2024 Feb 14, 2025	BUY	$1.16 - $1.77 $64,379 - $98,235	55,500 Added 2.28%	2,489,800 $3.31 Million
Q3 2024 Nov 14, 2024	BUY	$1.62 - $2.03 $1.47 Million - $1.84 Million	907,800 Added 59.47%	2,434,300 $4.26 Million
Q2 2024 Aug 14, 2024	SELL	$1.62 - $2.85 $1.94 Million - $3.42 Million	-1,200,500 Reduced 44.02%	1,526,500 $2.53 Million
Q1 2024 May 15, 2024	SELL	$1.6 - $2.48 $2.8 Million - $4.33 Million	-1,747,891 Reduced 39.06%	2,727,000 $6.74 Million
Q4 2023 Feb 14, 2024	BUY	$1.66 - $2.41 $835,486 - $1.21 Million	503,305 Added 12.67%	4,474,891 $10.3 Million
Q3 2023 Nov 14, 2023	BUY	$1.55 - $3.31 $1.04 Million - $2.22 Million	671,440 Added 20.35%	3,971,586 $9.49 Million
Q2 2023 Aug 14, 2023	BUY	$1.52 - $2.78 $741,373 - $1.36 Million	487,746 Added 17.34%	3,300,146 $5.15 Million
Q1 2023 May 15, 2023	SELL	$2.36 - $3.35 $3.58 Million - $5.09 Million	-1,518,607 Reduced 35.06%	2,812,400 $7.12 Million
Q4 2022 Feb 14, 2023	BUY	$2.58 - $4.68 $454,425 - $824,307	176,134 Added 4.24%	4,331,007 $11.7 Million
Q3 2022 Nov 14, 2022	BUY	$2.7 - $4.3 $957,900 - $1.53 Million	354,778 Added 9.34%	4,154,873 $11.4 Million

380

113M

6.41M

6.21M

Ticker TLRY
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 611,401,984
Market Cap $581M
Description
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.